Keyphrases
Anti-inflammatory Activity
23%
Anti-inflammatory Effect
28%
Anxiety-like Behavior
22%
Arcuate nucleus
31%
Astroglial Cells
63%
Behavioral Impairment
29%
Brain Regions
24%
Brainstem
20%
C57BL
35%
Cerebellum
23%
Chemokine (C-C motif) Ligand 2 (CCL2)
50%
Chemokine Expression
44%
Chemokines
29%
CXCL10
100%
Dorsal Vagal Complex
33%
Enzyme-linked Immunosorbent Assay (ELISA)
25%
Human Astrocytes
21%
Inflammation
42%
Inflammatory Chemokines
30%
Inflammatory Pathways
44%
Interleukin-1β
40%
Interleukin-6
39%
Lipopolysaccharide
76%
Lipopolysaccharide-induced
84%
Lipopolysaccharide-induced Inflammation
29%
Liver
26%
Metabolic Hormones
29%
Monocyte Chemoattractant protein-1 (MCP-1)
32%
Mu-opioid Receptor Antagonist
24%
Neuroimmune Response
27%
Neuroimmune Signaling
29%
Neuroinflammation
85%
Neuropathic Pain
23%
NF-B
21%
Nicotinic Acetylcholine Receptor (nAChR)
31%
Nuclear factor-κB
27%
Obesity
20%
Ovariectomy
43%
OVX Rats
22%
PAM2
29%
Paraventricular nucleus
35%
Positive Allosteric Modulator
21%
Protective Effect
25%
Sickness
33%
Sickness Behavior
23%
Social Defeat
43%
Spleen
23%
Toll-like
22%
Weight Gain
39%
Whole Brain
22%
Neuroscience
Alzheimer's Disease
19%
Anti-Inflammatory
40%
Anti-Inflammatory Agent
14%
Anxiety Disorder
18%
Arcuate Nucleus
39%
Astrocyte
58%
Astrocytoma
14%
Behavior (Neuroscience)
38%
Blood Plasma
39%
CCL2
37%
Cerebellum
25%
Chemokine
71%
CXCL10
84%
Gamma Interferon Inducible Protein 10
21%
Ghrelin
21%
Glial Fibrillary Acidic Protein
25%
Hippocampus
24%
Hormone Receptor
13%
In Vitro
14%
In Vivo
18%
Inducible Nitric Oxide Synthase
14%
Interferon
16%
Interleukin 1
25%
Interleukin 6
30%
Leptin
24%
Leptin Receptor
17%
Lipopolysaccharide
87%
Messenger RNA
11%
Microglia
21%
Monocyte Chemotactic Protein 1
19%
Mood Disorder
20%
Naltrexone
24%
Narcotic Antagonist
36%
Necrosis
13%
Neurological Disorder
20%
Neuromelanin
14%
Neuroreceptor
14%
Nicotinic Acetylcholine Receptor
14%
Nitric Oxide Synthase
14%
Parkinson's Disease
14%
Pervasive Developmental Disorder
14%
Positive Allosteric Modulator
14%
Protein Expression
24%
Receptor
19%
Sickness Behavior
14%
Social Behavior
14%
Social Defeat
43%
Synuclein
14%
TLR 4
23%
μ-Opioid Receptor
24%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
9%
Alzheimer's Disease
12%
Anti-Inflammatory Drug
28%
Antiinflammatory Activity
27%
Antiinflammatory Agent
16%
Anxiety Disorder
14%
C57BL 6 Mouse
14%
Chemokine
95%
Chemotherapy
14%
Cytokine
35%
Disease
91%
Duragesic
9%
Enzyme-Linked Immunosorbent Assay
22%
Gamma Interferon Inducible Protein 10
20%
Ghrelin
14%
Glial Fibrillary Acidic Protein
16%
Heavy Metal
14%
HIV
14%
Immunoglobulin Enhancer Binding Protein
9%
Inducible Nitric Oxide Synthase
14%
Inflammation
59%
Interferon
25%
Interleukin 1
16%
Interleukin 6
35%
Leptin
14%
Lipopolysaccharide
93%
Lipopolysaccharide-Induced Inflammation
43%
Lipopolysaccharide-Induced Neuroinflammation
24%
Monocyte Chemotactic Protein 1
10%
Mood Disorder
17%
Mouse Model
14%
Mu Opiate Receptor Antagonist
21%
Naltrexone
26%
Narcotic Antagonist
22%
Nervous System Inflammation
60%
Neurologic Disease
22%
Neuropathic Pain
21%
Nicotinic Receptor
31%
Nitric Oxide Synthase
14%
Normal Human
19%
Nuclear Factor
9%
Opiate
11%
Oxaliplatin
10%
Pharmacotherapy
14%
Positive Allosteric Modulator
43%
Receptor
14%
Toll Like Receptor 4
16%
Tumor Necrosis Factor
47%
Western Blot
9%
μ-Opioid Receptor
13%